The new scope of condition-specific markers, NGS and genomics with advances in molecular diagnostics caters to need of rapid diagnostics, early detection and point-of-care testing. Various technological developments and advancements in in vitro diagnostics have led to a new variety of diagnostic tests, allowing patients to access novel treatments earlier.

20% discount on registration for United Life Sciences members.

For more information and to register click here.